Pharmaxis

Pharmaxis is a pharmaceutical research company with approved products on the market and a drug discovery team dedicated to developing new drugs for the treatment of inflammation and fibrosis. Its product Aridol® is key for assessing asthma and is sold in international markets. Its product Bronchitol® has recently been launched in Europe and Australia for cystic fibrosis. Its development pipeline includes products for bronchiectasis, PXS64 Bronchitol for marketing approval, for the treatment of pulmonary fibrosis, ASM8 for asthma, and PXS4728 for fibrotic diseases.